Wed, Jul 30, 2014, 2:39 AM EDT - U.S. Markets open in 6 hrs 51 mins

Recent

% | $
Click the to save as a favorite.

Insmed Incorporated Message Board

  • blank2thisone blank2thisone Dec 24, 2012 1:13 PM Flag

    Why did we miss this important line in latest 10q?

    Additionally, in the quarter ended June 30, 2012, we entered into contracts totaling $3.0 million for the manufacturing...

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • did not, but why not reference the entire statement of two sentences?

      "In January 2012, we entered into a contract with our drug supply manufacturer for drug required for our dog toxicology study at a total cost of $1.4 million. Additionally, in the quarter ended June 30, 2012, we entered into contracts totaling $3.0 million for the manufacturing of clinical drug supplies."

      Now we need to debate is what is included in "clinical drug supplies." I am sure that more than one drug will enter into this discussion, even though the CRO/cGMP manufacturer of Arikace liposome is specifically named in the revised INSM investor presentation.

      Longs should buy or hold for the right reasons. Not "half-truth" opinions of Spumpers.

      Sentiment: Buy

      • 1 Reply to rehdvm2004
      • by rehdvm2004.Dec 24, 2012 3:43 PM.PermalinkGo to topic
        .

        did not, but why not reference the entire statement of two sentences?

        "In January 2012, we entered into a contract with our drug supply manufacturer for drug required for our dog toxicology study at a total cost of $1.4 million. Additionally, in the quarter ended June 30, 2012, we entered into contracts totaling $3.0 million for the manufacturing of clinical drug supplies."

        Now we need to debate is what is included in "clinical drug supplies." I am sure that more than one drug will enter into this discussion, even though the CRO/cGMP manufacturer of Arikace liposome is specifically named in the revised INSM investor presentation.

        Longs should buy or hold for the right reasons. Not "half-truth" opinions of Spumpers.

        Sentiment: Buy

    • Here is the context of what you truncated....

      "In January 2012, we entered into a contract with our drug supply manufacturer for drug required for our dog toxicology study at a total cost of $1.4 million. Additionally, in the quarter ended June 30, 2012, we entered into contracts totaling $3.0 million for the manufacturing of clinical drug supplies."

 
INSM
17.50+0.40(+2.34%)Jul 29 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Twitter, Inc.
NYSETue, Jul 29, 2014 4:04 PM EDT
El Pollo Loco Holdings, Inc.
NasdaqGSTue, Jul 29, 2014 4:00 PM EDT
Windstream Holdings, Inc.
NasdaqGSTue, Jul 29, 2014 4:00 PM EDT